Elsevier

Medical Hypotheses

Volume 7, Issue 11, November 1981, Pages 1359-1376
Medical Hypotheses

Vitamin C, TITRATING TO BOWEL TOLERANCE, ANASCORBEMIA, and ACUTE INDUCED SCURVY

https://doi.org/10.1016/0306-9877(81)90126-2Get rights and content

Abstract

A method of utilizing vitamin C in amouts just short of the doses which produce diarrhea is described (TITRATING TO BOWEL TOLERANCE). The amount of oral ascorbic acid tolerated by a patient without producing diarrhea increases somewhat proportionately to the stress or toxicity of his disease. Bowel tolerance doses of ascorbic acid ameliorate the acute symptoms of many diseases. Lesser doses often have little effect on acute symptoms but assist the body in handling the stress of disease and may reduce the morbidity of the disease. However, if doses of ascorbate are not provided to satisfy this potential draw on the nutrient, first local tissues involved in the disease, then the blood, and then the body in general become deplete of ascorbate (ANASCORBEMIA and ACUTE INDUCED SCURVY). The patient is thereby put at risk for complications of metabolic processes known to be dependent upon ascorbate.

References (32)

  • N. Subramanian

    Detoxification of histamine with ascorbic acid

    Biochemical Pharmacology

    (1973)
  • R.F. Cathcart

    Clinical trial of vitamin C

    Medical Tribune

    (June 25, 1975)
  • R.F. Cathcart

    Clinical use of large doses of ascorbic acid

  • R.F. Cathcart

    Vitamin C as a detoxifying agent

  • R.F. Cathcart

    Vitamin C — The missing stress hormone

  • R.F. Cathcart

    The method of determining proper doses of vitamin C for the treatment of disease by titrating to bowel tolerance

    J. Orthomolecular Psychiatry

    (1981)
  • F.R. Klenner

    Virus pneumonia and its treatment with vitamin C

    J. South. Med. and Surg.

    (1948)
  • F.R. Klenner

    The treatment of poliomyelitis and other viral diseases with vitamin C

    J. South. Med. and Surg.

    (1949)
  • F.R. Klenner

    Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology

    J. App. Nutr.

    (1971)
  • F.R. Klenner

    Significance of high daily intake of ascorbic acid in preventive medicine

    J. Int. Acad. Prev. Med.

    (1974)
  • I. Stone

    Studies of a mammalian enzyme system for producing evolutionary evidence on man

    Am. J. Phys. Anthro.

    (1965)
  • I. Stone

    Hypoascorbemia: The genetic disease causing the human requirement for exogenous ascorbic acid

    Perspectives in Biology and Medicine

    (1966)
  • I. Stone
  • L. Pauling
  • L. Pauling
  • E. Cameron et al.

    Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer

  • Cited by (0)

    View full text